These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27651156)

  • 1. Structural and Practical Identifiability Issues of Immuno-Epidemiological Vector-Host Models with Application to Rift Valley Fever.
    Tuncer N; Gulbudak H; Cannataro VL; Martcheva M
    Bull Math Biol; 2016 Sep; 78(9):1796-1827. PubMed ID: 27651156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15.
    Mroz C; Gwida M; El-Ashker M; El-Diasty M; El-Beskawy M; Ziegler U; Eiden M; Groschup MH
    BMC Vet Res; 2017 Apr; 13(1):87. PubMed ID: 28381251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vector-Borne Pathogen and Host Evolution in a Structured Immuno-Epidemiological System.
    Gulbudak H; Cannataro VL; Tuncer N; Martcheva M
    Bull Math Biol; 2017 Feb; 79(2):325-355. PubMed ID: 28032207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network-based meta-population approach to model Rift Valley fever epidemics.
    Xue L; Scott HM; Cohnstaedt LW; Scoglio C
    J Theor Biol; 2012 Aug; 306():129-44. PubMed ID: 22564391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States.
    Golnar AJ; Kading RC; Hamer GL
    Transbound Emerg Dis; 2018 Feb; 65(1):85-95. PubMed ID: 28191786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecific network centrality, host range and early-life development are associated with wildlife hosts of Rift Valley fever virus.
    Walsh MG; Mor SM
    Transbound Emerg Dis; 2018 Dec; 65(6):1568-1575. PubMed ID: 29756406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Practical Identifiability Analysis of Zika Epidemiological Models.
    Tuncer N; Marctheva M; LaBarre B; Payoute S
    Bull Math Biol; 2018 Aug; 80(8):2209-2241. PubMed ID: 29948883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of Rift Valley Fever with human host.
    Mpeshe SC; Haario H; Tchuenche JM
    Acta Biotheor; 2011 Dec; 59(3-4):231-50. PubMed ID: 21611886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
    Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rift Valley Fever: a Threat to Pregnant Women Hiding in Plain Sight?
    McMillen CM; Hartman AL
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity Analysis in an Immuno-Epidemiological Vector-Host Model.
    Gulbudak H; Qu Z; Milner F; Tuncer N
    Bull Math Biol; 2022 Jan; 84(2):27. PubMed ID: 34982249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes.
    Vloet RPM; Vogels CBF; Koenraadt CJM; Pijlman GP; Eiden M; Gonzales JL; van Keulen LJM; Wichgers Schreur PJ; Kortekaas J
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006145. PubMed ID: 29281642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking the chain: Rift Valley fever virus control via livestock vaccination.
    Bird BH; Nichol ST
    Curr Opin Virol; 2012 Jun; 2(3):315-23. PubMed ID: 22463980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic, climate-driven model of Rift Valley fever.
    Leedale J; Jones AE; Caminade C; Morse AP
    Geospat Health; 2016 Mar; 11(1 Suppl):394. PubMed ID: 27063737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
    Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
    Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007.
    Seufi AM; Galal FH
    BMC Infect Dis; 2010 Mar; 10():65. PubMed ID: 20222979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical study of a Rift Valley fever epidemic.
    Jouan A; Coulibaly I; Adam F; Philippe B; Riou O; Leguenno B; Christie R; Ould Merzoug N; Ksiazek T; Digoutte JP
    Res Virol; 1989; 140(2):175-86. PubMed ID: 2787923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR.
    Mwaengo D; Lorenzo G; Iglesias J; Warigia M; Sang R; Bishop RP; Brun A
    Virus Res; 2012 Oct; 169(1):137-43. PubMed ID: 22841800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.